Stephen J. Leary serves as Executive at CURAXIS PHARMACEUTICAL Corp, where they oversee executive responsibilities. Since joining the company, Stephen J. Leary has executed 6 insider transactions totaling $15.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 19, 2012 involved receiving (via award) 200,000 shares valued at $8.0K.
Stephen J. Leary currently holds 617,509 shares of CURAXIS PHARMACEUTICAL Corp (CURX.PK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen J. Leary has been a net buyer of CURX.PK stock. They have purchased $15.0K and sold $0 worth of shares.
Stephen J. Leary's most recent insider trade was on Jan 19, 2012, when they sold 200,000 shares at $0.04 per share.
Get notified when new Form 4 filings are submitted
| 39,229 |
| $0.08 |
| Discretionary |
| Nov 17, 2011 | CURX.PK | $4.4K | Award | 55,000 | $0.08 | Discretionary |
| Oct 3, 2011 | CURX.PK | $0 | Purchase | 50,000 | $N/A | Discretionary |
| Sep 16, 2011 | CURX.PK | $5.0K | Purchase | 100,000 | $0.05 | Discretionary |
| Aug 15, 2011 | CURX.PK | $10.0K | Purchase | 200,000 | $0.05 | Discretionary |